Olfaction in the autism spectrum

Centre d'Excellence en Troubles Envahissants du Développement de I'Université de Montréal (CETEDUM), Montréal, QC, Canada.
Perception (Impact Factor: 1.11). 01/2013; 42(3):341-55. DOI: 10.1068/p7337
Source: PubMed

ABSTRACT The autism spectrum (AS) is characterised by enhanced perception in vision and audition, described by the enhanced perceptual functioning (EPF) model. This model predicts enhanced low-level (discrimination of psychophysical dimensions), and mid- and high-level (pattern detection and identification) perception. The EPF model is here tested for olfaction by investigating olfactory function in autistic and Asperger participants. Experiment 1 targeted higher-order olfactory processing by assessing olfactory identification in nine Asperger, ten autistic, and eleven typically developed individuals. Experiment 2 focused on low-level olfactory processing; we assessed odour detection thresholds and odour discrimination in five Asperger, five autistic, and five typically developed males. Olfactory identification was impaired in autistic participants relative to control and Asperger participants. Typical performance in low-level olfactory processing suggests that neural mechanisms involved in the perceptual phenotype of AS do not affect structures implicated in olfactory processing. Reduced olfactory identification is limited to autistic participants who displayed speech delay and may be due to a reduced facility to use verbal labels. The apparent absence of enhanced olfactory perception of AS participants distinguishes the olfactory system from the other sensory modalities and might be caused by the absence of an obligatory thalamic relay.


Available from: Laurent Mottron, Mar 02, 2014
  • Source
    Frontiers in Psychology 01/2014; 5:42. DOI:10.3389/fpsyg.2014.00042 · 2.80 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Analysis of dynamics of biologically motivated neural networks allows for studying non-linear processes responsible for cognitive functions and thus provides adequate language to understand complex mental processes, including psychiatric syndromes and disorders. Problems with attention shifts that are at the roots of Autism Spectrum Disorders (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD), have been investigated using network model of Posner Visual Orienting Task (PVOT). Changing parameters that control biophysical properties of model neurons and cause network dysfunctions provides plausible explanations of many strange ASD and ADHD phenomena.
    Neural Information Processing, ICONIP 2013, Part I, LNCS 8226, Edited by Minho Lee, Akira Hirose, Zeng-Guang Hou, Rhee Man Kil, 01/2013: pages 623-630; Springer-Verlag Berlin Heidelberg., ISBN: 978-3-642-42053-5
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: DNA mutational events are increasingly being identified in autism spectrum disorder (ASD), but the potential additional role of dysregulation of the epigenome in the pathogenesis of the condition remains unclear. The epigenome is of interest as a possible mediator of environmental effects during development, encoding a cellular memory reflected by altered function of progeny cells. Advanced maternal age (AMA) is associated with an increased risk of having a child with ASD for reasons that are not understood. To explore whether AMA involves covert aneuploidy or epigenetic dysregulation leading to ASD in the offspring, we tested a homogeneous ectodermal cell type from 47 individuals with ASD compared with 48 typically developing (TD) controls born to mothers of ≥35 years, using a quantitative genome-wide DNA methylation assay. We show that DNA methylation patterns are dysregulated in ectodermal cells in these individuals, having accounted for confounding effects due to subject age, sex and ancestral haplotype. We did not find mosaic aneuploidy or copy number variability to occur at differentially-methylated regions in these subjects. Of note, the loci with distinctive DNA methylation were found at genes expressed in the brain and encoding protein products significantly enriched for interactions with those produced by known ASD-causing genes, representing a perturbation by epigenomic dysregulation of the same networks compromised by DNA mutational mechanisms. The results indicate the presence of a mosaic subpopulation of epigenetically-dysregulated, ectodermally-derived cells in subjects with ASD. The epigenetic dysregulation observed in these ASD subjects born to older mothers may be associated with aging parental gametes, environmental influences during embryogenesis or could be the consequence of mutations of the chromatin regulatory genes increasingly implicated in ASD. The results indicate that epigenetic dysregulatory mechanisms may complement and interact with DNA mutations in the pathogenesis of the disorder.
    PLoS Genetics 05/2014; 10(5):e1004402. DOI:10.1371/journal.pgen.1004402 · 8.52 Impact Factor